EX-21.1 5 mrtx-20221231xex211.htm EX-21.1 Document

Exhibit 21.1

SubsidiaryCountry of Origin
MethylGene Inc.Canada
Mirati Therapeutics B.V.Netherlands
Mirati Therapeutics (Suisse) GmbH
Switzerland